• Oral Administration: Eliglustat is taken orally as a tablet. It should be taken exactly as prescribed by your healthcare provider.
  
  
• Administration with Food: Eliglustat can be taken with or without food. However, taking it with food may help reduce any stomach discomfort.
  
  
• Missed Dose: If you miss a dose of Eliglustat, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not take two doses at once to make up for a missed dose.
  
  

Regular Monitoring: Your doctor may perform regular tests to monitor liver function, as liver impairment can influence how Eliglustat works in your body.

Eliglustat works by inhibiting glucosylceramide synthase, an enzyme involved in the production of glucocerebroside. In people with Gaucher disease, the enzyme glucocerebrosidase is deficient, leading to the build-up of glucocerebroside in cells. This accumulation can cause enlarged organs, bone damage, and other complications.

• Inhibition of Glucosylceramide Synthase: Eliglustat targets and inhibits the enzyme glucosylceramide synthase, which is responsible for synthesizing glucocerebroside. By reducing its production, Eliglustat helps to decrease the overall buildup of glucocerebroside, alleviating symptoms associated with Gaucher disease.
  
  

Symptom Relief: Through this mechanism, Eliglustat helps improve liver and spleen size, reduce bone pain, and support the improvement of overall quality of life for patients with Gaucher disease.

Eliglustat is generally well-tolerated, but, like any medication, it may cause side effects. Some common side effects include:

• Diarrhea: Some people may experience gastrointestinal issues, such as diarrhea or stomach cramps.
  
  
• Headache: Headaches are a common side effect reported by patients using Eliglustat.
  
  
• Fatigue: Some patients report feeling unusually tired or weak while on treatment.
  
  
• Nausea: Mild nausea is possible, especially in the early stages of treatment.
  
  
• Liver Issues: Eliglustat can affect liver function, leading to liver enzyme elevations. Regular monitoring of liver function is recommended during treatment.
  
  
• Low Blood Sugar: In rare cases, Eliglustat can cause hypoglycemia (low blood sugar).
  
  
• Rash: Some patients may develop skin rashes while on treatment.
  
  

Serious side effects are rare, but if you experience any signs of liver problems (e.g., yellowing of the skin or eyes, dark urine, severe stomach pain), contact your healthcare provider immediately.

• Liver Impairment: Eliglustat should be used with caution in individuals with liver problems. It is contraindicated in patients with severe liver impairment (Child-Pugh Class C). Regular liver function tests are recommended.
  
  
• Pregnancy and Breastfeeding: The safety of Eliglustat during pregnancy and breastfeeding is not fully established. It should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Women who are breastfeeding should consult their doctor before using this medication.
  
  
• Genetic Testing: Before starting treatment with Eliglustat, genetic testing for CYP2D6 metabolizer status is required. This helps determine the appropriate dose and ensures optimal efficacy.
  
  

Risk of Infections: As with many treatments for genetic disorders, patients should be monitored for signs of infections or other adverse effects that may arise due to reduced immune function.

• 
  
  • CYP2D6 Inhibitors: Eliglustat is metabolized by the liver enzyme CYP2D6. Medications that inhibit this enzyme, such as fluoxetine or paroxetine, can increase the levels of Eliglustat in the body, requiring dose adjustments.
    
    
  • Strong CYP3A4 Inhibitors: Drugs like ketoconazole and itraconazole can increase the levels of Eliglustat, which may require dose adjustments.
    
    
  • CYP3A4 Inducers: Medications such as rifampin and carbamazepine can reduce Eliglustat levels, potentially requiring dose increases.
    
    
  • Always inform your doctor about all the medications and supplements you are taking to avoid potential interactions.
    
    

• Starting Dose: The starting dose is typically 84 mg twice daily for most patients with mild to moderate Gaucher disease type 1.
  
  
• Adjustments: The dose may be reduced if you are a poor metabolizer of CYP2D6 or if you have liver impairment. Your doctor will adjust the dosage based on your genetic profile and liver function tests.
  
  
• Regular Monitoring: It is essential to undergo regular check-ups to assess liver function and other health parameters, particularly when starting the treatment.
  
  

Eliglustat is a prescription medication, meaning it must be prescribed by a healthcare provider. Before initiating treatment, your doctor will perform a thorough assessment, which may include genetic testing to determine your CYP2D6 metabolizer status and liver function tests. Ongoing monitoring will be required during treatment to ensure the medication is working effectively and safely.

• What is Eliglustat?
  Eliglustat is an oral medication used to treat Gaucher disease type 1.

• How does Eliglustat work?
  It reduces the production of a fatty substance (glucosylceramide) that builds up in patients with Gaucher disease.

• Who can take Eliglustat?
  It is prescribed to adults with Gaucher disease type 1 who are suitable candidates based on genetic testing.

• Is Eliglustat safe for children?
  No, it is not approved for pediatric use.

• How is Eliglustat taken?
  It is usually taken orally, once or twice a day, depending on the patient’s CYP2D6 metabolizer status.

• Do I need genetic testing before taking Eliglustat?
  Yes, genetic testing for CYP2D6 enzyme activity is required to determine the correct dosage.

• Can Eliglustat cure Gaucher disease?
  No, it does not cure Gaucher disease but helps manage symptoms and reduce organ enlargement.

• What are the common side effects of Eliglustat?
  Fatigue, headache, nausea, diarrhea, abdominal pain, and dizziness.

• Are there serious risks with Eliglustat?
  Yes, it may cause heart rhythm problems and drug interactions in some patients.

• Can Eliglustat be taken during pregnancy?
  It should only be used during pregnancy if clearly needed and prescribed by a doctor.

• Is Eliglustat safe while breastfeeding?
  It is not known if Eliglustat passes into breast milk; consult a healthcare provider.

• Can I drink alcohol while taking Eliglustat?
  Alcohol may worsen side effects like dizziness and should be limited or avoided.

• Does Eliglustat interact with other medications?
  Yes, it can interact with strong CYP2D6 and CYP3A inhibitors/inducers.

• Can Eliglustat replace enzyme replacement therapy (ERT)?
  For some patients, it can be used as an alternative to ERT for Gaucher disease type 1.

• How long do I need to take Eliglustat?
  It is usually a lifelong treatment unless discontinued by a doctor.

• What should I do if I miss a dose of Eliglustat?
  Take the next dose at the regular time; do not double up.

• Is Eliglustat a generic drug?
  No, currently it is only available as a brand-name drug.

• What brand name is Eliglustat sold under?
  It is sold under the brand name Cerdelga.

• Is Eliglustat available worldwide?
  It is available in the U.S., EU, and other regions, but availability may vary by country.

• Do I need a prescription for Eliglustat?
  Yes, it is a prescription-only medication.